Table 2.
Levels of plasma adipocytokines and chemokines.
| Protein | Early RA/(no = 70) |
|---|---|
| Total Adiponectin (mg/L) | 6.0 (4.0–10.3) |
| HMW Adiponectin (mg/L) | 3.0 (1.5–5.2) |
| Leptin (ng/mL) | 13.2 (4.7–35.3) |
| Resistin (ng/mL) * | 10.1 (7.8–13.4) |
| CXCL8/IL-8 | 489 (162–1001) |
| CXCL10/IP-10 | 1024 (748–1859) |
| CCL17/TARC | 301 (215–516) |
| CCL2/MCP-1 | 960 (746–1195) |
| CCL5/RANTES | 17,538 (13,354–22,134) |
| CCL3/MIP-1α * | 29 (14–56) |
| CXCL9/MIG * | 245 (89–813) |
| CXCL5/ENA-78 | 547 (311–762) |
| CCL20/MIP-3α * | 25 (2–74) |
| CXCL1/GROα * | 214 (147–341) |
| CXCL11/I-TAC | 985 (736–1446) |
| CCL4/MIP-1β * | 44 (28–72) |
| CCL22/MDC | 466 (356–620) |
| CXCL13/BCL | 490 (205–990) |
| CCL11/Eotaxin | 732 (628–1056) |
Data shown as median (interquartile range). All units are in pg/mL, unless otherwise noted. * Resistin was under detection limit in 1% of samples, CCL3/MIP-1α in 15%, CXCL9/MIG in 14%, CCL20/MIP-3a in 35%, CXCL1/GROα in 17%, and CCL4/MIP-1β in 11%.